Report #2870600

Received Nov 4, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: Oct 19, 2025
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

FatigueHeadache

Symptom narrative

still tired w/ headache; Headache; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 19-OCT-2025, the patient received Shingrix. The patient experienced tiredness (Verbatim: still tired w/ headache) and headache (Verbatim: Headache). The outcome of the tiredness and headache were not resolved. It was unknown if the reporter considered the tiredness and headache to be related to Shingrix. It was unknown if the company considered the tiredness and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 21-OCT-2025 The batch number was not provided, and we are unable to contact the reporter.